Exelixis, Inc. (EXEL)
43.50
-0.32
(-0.74%)
USD |
NASDAQ |
Jan 02, 15:15
Exelixis EPS Diluted (TTM): 2.375 for Sept. 30, 2025
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Vanda Pharmaceuticals, Inc. | -1.432 |
| ADMA Biologics, Inc. | 0.8515 |
| Aldeyra Therapeutics, Inc. | -0.7218 |
| Neurocrine Biosciences, Inc. | 4.187 |
| Axsome Therapeutics, Inc. | -4.673 |